Lack of bcl-2 persistence: An independent prognostic indicator of poor prognosis in endometrial carcinoma

Gynecologic Oncology

Volumn 71, Issue 2, 1998, Pages 305-307

  Geisler, John P ^a   Geisler, Hans E ^a   Wiemann, Michael C ^a   Zhou, Zhen ^b   Miller, Greg A ^b   Crabtree, William ^b  

^a ST VINCENT HOSPITAL   (United States)

^b Dept of Pathol Lab for D ^*  (United States)

Author keywords

Bcl 2; Endometrial cancer; Recurrence

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; CELL DEATH; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPEROXIDASE STAINING; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN SYNTHESIS INHIBITION; PROTO ONCOGENE; RECURRENT DISEASE;

EID: 0032211921     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1998.5192     Document Type: Article

References (13)

1. Vaux D L, Cory S, Adams J M. Bcl-2 gene promotes haemopoietic cell and cooperates with c-myc to immortalize pre-B cell. Nature. 335:1988;440-442.
2. Saegusa M, Takano Y, Hashimura M, Shoji Y, Okayasu I. The possible role of bcl-2 expression in the progression of tumors of the uterine cervix. Cancer. 76:1995;2297-2303.
3. Cleary M L, Smith S D, Sklar J. Cloning and structural analysis of cDNA for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell. 47:1986;19-28.
4. Zheng W, Cao P, Zheng M, Kramer E E, Godwin T A. p53 overexpression and bcl-2 persistence in endometrial carcinoma: comparison of papillary serous and endometrioid subtypes. Gynecol Oncol. 61:1996;167-174.
5. Diebold J, Baretton G, Felchner M, Meier W, Dopfer K, Schmidt M, Lohrs U. bcl-2 expression, p53 accumulation, and apoptosis in ovarian carcinomas. Am J Clin Pathol. 105:1996;341-349.
6. Herod J JO, Eliopoulos A G, Warwick J, Niedobitek G, Young L S, Kerr D J. The prognostic significance of Bcl-2 and p53 expression ovarian carcinoma. Cancer Res. 56:1996;2178-2184.
7. Announcements. FIGO stages - 1988 revision. Gynecol Oncol. 35:1989;125-127.
8. Geisler J P, Zhou Z, Miller G A, Wiemann M C, Geisler H E. Proliferation index determined by MIB-1 and recurrence in endometrial cancer. Gynecol Oncol. 61:1996;373-377.
9. Geisler J P, Zhou Z, Miller G A, Wiemann M C, Geisler H E. Markov texture parameters as prognostic indicators in endometrial cancer. Gynecol Oncol. 62:1996;174-180.
10. Gompel A, Sabourin J C, Matin A, Yaneva H, Audouin J, Decroix Y, Poitout P. Bcl-2 expression in normal endometrium during the menstrual cycle. Am J Pathol. 143:1994;390-400.
11. Fotedar R, Diederich L, Fotedar A. Apoptosis and the cell cycle. Prog Cell Cycle Res. 2:1996;147-163.
12. Berardo M D, Elledge R M, de Moor C, Clark G M, Osborne C K, Allred D C. bcl-2 and apoptosis in lymph node positive breast carcinoma. Cancer. 82:1998;1296-1302.
13. van Slooten H J, van de Vivjer, van de Velde C J, van Dierendonck J H. Loss of bcl-2 in invasive breast cancer is associated with high rates of cell death, but also with increased proliferative activity. Br J Cancer. 77:1998;789-796.